Article
Investigation of the therapeutic efficacy and resistance mechanisms of lytic phages targeting ST218 KL57 CR-hvKP.
mSystems - 17 Feb 2026
Dou Liuqing, Li Jiayang, Wu Wenqi, Xu Li, Qiu Mingjie, Yang Shuanghong, Wang Jiajie, Tian Sai, Zhou Zhitao, Wu Meilin, Zhao Yun, Wu Xiuwen, Ren Jianan
Abstract excerpt
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) infection is gradually increasing globally. Phage therapy is a viable application as an alternative to antibiotics. However, clinical application of phage therapy is restricted by phage resistance. To further explore the mechanism underlying phage resistance, particularly the difference observed between in vivo and in vitro, we employed a mouse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
